Determination of Azelastine Hydrochloride and Benzalkonium Chloride in Their Ophthalmic Solution by Different Spectrophotometric Methods
World Journal of Applied Chemistry
Volume 2, Issue 2, May 2017, Pages: 48-56
Received: Feb. 8, 2017; Accepted: Feb. 23, 2017; Published: Mar. 10, 2017
Views 1729      Downloads 81
Authors
Mohamed E. M. Hassouna, Chemistry Department, Faculty of Science, Beni-Suef University, Beni-Suef, Egypt
Maha M. Abdelrahman, Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt
Mahmoud A. Mohamed, HIKMA Group, Pharmaceutical Company, Beni-Suef, Egypt
Article Tools
Follow on us
Abstract
Three simple, specific, accurate and precise spectrophotometric methods for the determination of a binary mixture of Azelastine hydrochloride (AZH) and Benzalkonium chloride (BAC) in pure and in their Dosage forms. The methods namely; (A) zero order (D0), (B) ratio difference (RD) and (C)ratio subtraction (RS). In method (A), AZH could be directly determined in the zero order at wave length equals to 284 nm in the range (5.0–50 μg/mL) with good correlation coefficient (0.9994), where no interference from BAC is reported. While BAC was determined by different methods in the range (2.0–30 μg/mL). In method (B) BAC determination depends on dividing the spectrum of the binary mixture by the standard spectrum of 20μg/mL AZH as a divisor, then BAC is determined using the difference between the two wavelengths 262 & 208 nm, we here BAC has absorbances and AZH is constant, the difference = (ΔP262.0-208.0) with good correlation coefficient (0.9994). Finally, in method (C) BAC can be determined by dividing the spectrum of the binary mixture by the standard spectrum of 10 μg/mL AZH as a dvisor, then a constant, which is determined as the mean value of the absorbances in the plateau region (230–300 nm), is subtracted; after multiplication by the divisor we obtain a zero order (D0) original spectrum of BAC at 208.0 nm with good correlation coefficient (0.9992). Accuracy, recovery and the selectivity of the developed methods are applied on the laboratory prepared mixtures, standard addition technique and pharmaceutical dosage form. The obtained results for the suggested methods are statistically compared with the reported HPLC one using student’s-t and F-ratio tests, showing that the two methods are accurate and precise.
Keywords
Azelastine Hydrochloride, Benzalkonium Chloride, Ophthalmic Solution, Zero Order (D0), Ratio Subtraction Method (RS), Ratio Difference Method (RD)
To cite this article
Mohamed E. M. Hassouna, Maha M. Abdelrahman, Mahmoud A. Mohamed, Determination of Azelastine Hydrochloride and Benzalkonium Chloride in Their Ophthalmic Solution by Different Spectrophotometric Methods, World Journal of Applied Chemistry. Vol. 2, No. 2, 2017, pp. 48-56. doi: 10.11648/j.wjac.20170202.12
Copyright
Copyright © 2017 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
References
[1]
British Pharmacopoeia, Stationary Office, Medicines and Healthcare Products Regulatory Agency, London, Vol. II, 2017.
[2]
The Merck Index: An Encyclopedia of Chemicals, Drugs and Biological., S. Budavari (Ed.), Merck &Co., Inc., Whitehouse Station, NJ 15th Ed, 2006.
[3]
S. C. Sweetman, Martindale: The Complete Drug Reference, 36th Ed., The Pharmaceutical Press, London, 2007.
[4]
J. M. Horbal, J. A. Bernstein, "Azelastine HCl: A Review of the Old and New Formulations", Journal of Clinical Medicine Insights: Therapeutics, 2; 427-437, 2010.
[5]
G. A. Gomez, A. M. Gonzalez, T. J. Garces, S. J. Costa, "Determination of benzalkonium chloride in aqueous ophthalmic preparations by high-performance liquid chromatography", Journal of Pharm Biomed Anal. 8(8-12); 871-6, 1990.
[6]
European Pharmacopeia 8th edition, 2014.
[7]
The United States Pharmacopoeia, 38th Revision, NF33, The United States Pharmacopoeia Convention Inc., June1, 2015.
[8]
A. A. Gouda, R. ElSheikh, H. ElSaied, "Extractive Spectrophotometric Determination of Azelastine Hydrochloride in Pure Form and Pharmaceutical Formulations", Canadian Chemical Transactions, 3 (1); 29-41, 2015.
[9]
T. Haraguchi, M. S. Nothenberg, "Volumetric and spectrophotometric assays of azelastine hydrochloride", Rev. Bras. Cienc. Farm.35; 127–131, 1999.
[10]
N. N. Salama, S. A. Abdel-razeq, S. Abdel-Atty, N. El-Kosy, "Spectrophotometric determination and thermodynamic studies of the charge transfer complexes of azelastine-HCl", Bull. Fac. Pharm. Cairo Univ., 49; 13-18, 2011.
[11]
R. T. Sane, S. G. Joshi, M. Francis, A. R. Khatri, P. S. Hijli, "Extractive colorimetric determination of Azelastine hydrochloride from its pharmaceutical preparations", Indian Drugs, 36; 317–320, 1999.
[12]
M. R. Elghobashy, O. M. Badran, M. Y. Salem, K. M. Kelani, "Stability indicating spectrophotometric and chromatographic methods for the determination of azelastine hydrochloride in presence of its alkaline degradant", Analytical Chemistry: An Indian J., 14 (4), 2014.
[13]
H. A. Merey, S. S. El-Mosallamy, N. Y. Hassan, B. A. El-Zeany, "Simultaneous determination of Fluticasone propionate and Azelastine hydrochloride in the presence of pharmaceutical dosage form additives", Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 160; 50-57, 2016.
[14]
R. T. Sane, S. G. Joshi, M. Francis, A. R. Khatri, P. S. Hijli, "High-performance thin layer chromatographic determination of azelastine hydrochloride", J. Planar. Chromatogr. modern TLC, 12; 158–160, 1999.
[15]
N. N. Salama, S. A. Abdel-Razeq, S. Abdel-Atty, N. El-Kosy, "Development and validation of densitometry TLC stability indicating method for quantitative determination of azelastine hydrochloride and emedastine difumarate in their drug products", British J. Pharm. Res., 4; 79-92, 2014.
[16]
R. Dubey, S. Das, S. Roychowdhury, K. K. Pradhan, M. Ghosh, "Validated HPTLC Method for the Determination of Azelastine hydrochloride in Bulk Drug and Dosage Form", PHARMBIT, 27 (1); 9-11, 2013.
[17]
E. Wyszomirska, K. Czerwi-Ska, E. Kublin, A. P. Mazurek, "Identification and determination of Ketotifen hydrogen fumarate, Azelastine hydrochloride, Dimetindene maleate and Promethazine hydrochloride by densitometric method", Acta Poloniae Pharmaceutica-DrugResearch, 70 (6); 951-959, 2013.
[18]
B. Koppenhoefer, A. Jakob, X. F. Zhu, B. C. Lin, "Separation of enantiomers of drugs by capillary electrophoresis with permethyl-gama-cyclodextrin as chiral solvating agent", J. High. Resol. Chromatogr. 23; 413–429, 2000.
[19]
N. Suzuki, Y. Ishihama, T. Kajima, N. Asakawa, "Quantitation of counterion of a water-insoluble drug by nonaqueous capillary electrophoresis within direct UVdetection", J. Chromatogr. A., 829, 411, 1998.
[20]
Y. S. Park, S. H. Kim, Y. J. Kim, S. C. Yang, M. H. Lee, L. M. Shaw, "Determination of Azelastine in Human Plasmaby Validated Liquid Chromatography Coupled to Tandom Mass Spectrometry (LCESI/MS/MS) for the Clinical Studies", Int. J. Biomed. Sci., 6; 120–127, 2010.
[21]
U. Heinemann, G. Blaschke, N. Knebel. “Simultaneous enantitio selective separation of azelastine and three of its metabolites for the investigation of the enantiomeric metabolism in rats. Liquid Chromatography ion spray tandem mass spectrometry and electrokinetic capillary chromatography”, J. Chromatogr. B. Anal. Technol. Biomed. Life. Sci., 793; 389–404, 2003.
[22]
T. Kajima, N. Asakawa, T. Hattori, T. Sato, Y. Miyake, "Optical resolution by high performance liquid chromatography, separation of enantiomeric azelastine hydrochloride by ionpair chromatography", YakugakuZasshi, 109; 570–573, 1989.
[23]
P. Yoo-Sin, K. Shin-Hee, K. Young-Jae, Y. Seok-Chul, L. Min-Ho, M. S. Leslie, K. Ju-Seop, "Determination of Azelastine in Human Plasma by Validated Liquid Chromatography Coupled toTandom Mass Spectrometry (LC-ESI/MS/MS) for the Clinical Studies", Int. J. Biomed. Sci., 6; 120-127, 2010.
[24]
T. Boovizhikannan, V. K. Palanirajan, "RP-HPLC determination of azelastine in pure and in ophthalmic formulation", Int. J. Pharm. Sci. Rev. Res, 17, 62, 2012.
[25]
K. L. N. Rao, K. P. Reddy, K. S. Babu, K. S. Raju, K. V. Rao, J. V. Shaik, "Simultaneous Estimation of Fluticasone propionate, Azelastine Hydrochloride, Phenyl ethyl alcohol and Benzalkonium chloride by RP-HPLC Method in Nasal spray preparations", International Journal of Research in Pharmaceutical Sciences1 (4), 473-480, 2010.
[26]
C. N. Langevin, J. Pivonka, J. K. Wichmann, N. Kucharczyk, R. D. Sofia, "High performance liquid chromatographic determination of azelastine and desmethyl azelastine in guinea pig plasma and lung tissue", Biomedical Chromatography. 7 (1): 7-11, 1993.
[27]
K. K. Rahul, S. R. Baviskar, S. K. Mahajan, "Assay Method Development and Validation for Simultaneous Estimation of Mometasone Furoate and Azelastine Hydrochloride by RP-HPLC", Asian Journal of Biochemical and Pharmaceutical Research, 4 (4), 31-39, 2014.
[28]
S. A. Abdel-razeq, M. M. Foaud, N. N. Salama, S. Abdel-Atty, N. El-Kosy, "Voltammetric determination of azelastine-HCl and emedastine difumarate in micellar solution at glassycarbon and carbon paste electrodes", Sensing in Electroanalysis. 6; 289-305, 2011.
[29]
M. R. Elghobashy, O. M. Badran, M. Y. Salem, K. M. Kelani," Application of Membrane Selective Electrodes for the Determination of Azelastine Hydrochloride in the Presence of its Alkaline Degradant in Eye Drops and Plasma", Anal. Bioanal. Electrochem., 5; 325-340, 2013.
[30]
S. A. Abdel-Razeq, N. N. Salama, S. Abdel-Atty, N. El-Kosy, "Thermo analytical study and purity determination of azelastine hydrochloride and emedastine difumarate", Pharm. Anal. Acta. 3 (8) 176-179, 2012; doi: 10.4172/2153-2435.1000176.
[31]
J. J. Halvax, G. Wiese, J. A. Arp, J. M. Vermeer, W. P. VanBennekom, A. Bult, "Rapid determination of benzalkonium chloride in pharmaceutical preparations with flow injection liquid-liquid extraction", J Pharm Biomed Anal., 8 (3); 243-52., 1990.
[32]
K. Kova´cs-Hadady, I. Fa´bia´n, "The determination of benzalkonium chloride in eye-drops by difference spectrophotometry", Journal of Pharmaceutical and Biomedical Analysis, 16; 733–740, 1998.
[33]
J. E. Parkin, "The assay of benzalkonium chloride in pilocarpine, hypromellose and polyvinyl alcohol ophthalmic drops by second-order derivative ultraviolet spectrophotometry", J Pharm Biomed Anal., 11 (7): 609-11, 1993.
[34]
A. Chyła, E. Zelazowska, "Using of thin-layer chromatography for identification and quantitative determination of benzalkonium chloride in eye drops", Acta Pol Pharm., 56 (6); 419-23, 1999.
[35]
R. B. Taylor, S. Toasaksiri, R. G. Reid, "Capillary electrophoresis and liquid chromatography in the analysis of some quaternary ammonium salts used in lozenges as antibacterial agents", J Capillary Electrophor., 5 (1-2); 45-50, 1998.
[36]
Y. H. Hou, C. Y. Wu, W. H. Ding, "Development and validation of acapillary zone electrophoresis method for the determination of benzalkonium chlorides in ophthalmic solutions", J Chromatogr A., 976 (1-2); 207-13,2002.
[37]
M. Jimidar, I. Beyns, R. Rome, R. Peeters, G. Musch, "Determination of benzalkonium chloride in drug formulations by capillary electrophoresis (CE)", Biomed Chromatogr., 12 (3); 128-30, 1998.
[38]
Z. R. Cybulski, "Determination of benzalkonium chloride by gas chromatography", J Pharm Sci., 73 (12): 1700-2, 1984.
[39]
J. Dudkiewicz-Wilczynska, J. Tautt, I. Roman, "Application of the HPLC method for benzalkonium chloride determination in aerosol preparations", J Pharm Biomed Anal., 34 (5); 909-20, 2004.
[40]
A. Gomez-Gomar, M. M. Gonzalez-Aubert, J. Garces-Torrents, J. Costa-Segarra, "Determination of benzalkonium chloride in aqueous ophthalmic preparations by high-performance liquid chromatography", J Pharm Biomed Anal., 8 (8-12);871-6,1990.
[41]
A. A. Al-Fakhory, I. Al-Kalak, M. J. Al-khatib, "Chromatographic Determination of Total Benzalkonium Chloride [BAC] in Some of Ophthalmic Preparations by HPLC", Bull. Damascus Univ. for Basic Sciences. 30 (2), 155-171, 2014.
[42]
F. Liu, K. P. Xiao, A. M. Rustum, "Determination of individual homologues and total content of benzalkonium chloride by reversed-phase high-performance liquid chromatography using a short butyl column", JAOAC Int., 92 (6): 1644-51, 2009.
[43]
S. J. Prince, H. J. McLaury, L. V. Allen, P. McLaury, "Analysis of benzalkonium chloride and its homologs: HPLC versus HPCE", J Pharm Biomed Anal., 19 (6); 877-82, 1999.
[44]
G. R. Takeoka, L. T. Dao, R. Y. Wong, L. A. Harden, "Identification of benzalkonium chloride in commercial grapefruit seedextracts", JAgric Food Chem., 53 (19); 7630-6, 2005.
[45]
G. l. Santoni, A. Medica, P. Gratteri, S. Furlanetto, SPinzauti, "High-performance liquid chromatographic determination of benzalkonium and naphazoline or tetrahydrozoline in nasal and ophthalmic solutions", Farmaco.1994, 40 (11); 751-4, 1994.
[46]
K. Kümmerer, A. Eitel, U. Braun, P. Hubner, F. Daschner, G. Mascart, M. Milandri, F. Reinthaler, J. Verhoef, "Analysis of benzalkonium chloride in the effluent from European hospitals by solid-phase extraction and high-performance liquid chromatography with post-column ion-pairing and fluorescence detection", J Chromatogr A., 774 (1-2); 281-6, 1997.
[47]
G. Ambrus, L. T. Takahashi, P. A. Marty, "Direct determination of benzalkonium chloride in ophthalmic systems by reversed-phase high-performance liquid chromatography", J Pharm Sci., 76 (2); 174-6, 1987.
[48]
J. r. ElrodL, T. G. Golich, J. A. Morley, "Determination of benzalkonium chloride in eye care products by high-performance liquid chromatography and solid-phase extraction or on-line column switching", J Chromatogr., 625 (2); 362-7, 1992.
[49]
T. Y. Fan, G. M. Wall, "Determination of benzalkonium chloride in ophthalmic solutions containing tyloxapol by solid-phase extraction and reversed-phase high-performance liquid chromatography", J Pharm Sci., 82 (11); 1172-4,1993.
[50]
R. Mallik, S. Raman, X. Liang, A. W. Grobin, D. Choudhury, "Development and validation of a rapid ultra-high performance liquid chromatography method for the assay of benzalkonium chloride using a quality-by-design approach", J Chromatogr A.,1413; 22-32, 2015.
[51]
D. F. Marsh, L. T. Takahashi, "Determination of benzalkonium chloride in the presence of interfering alkaloids and polymeric substrates by reverse-phase high-performance liquid chromatography", J Pharm Sci., 72 (5); 521-5, 1983.
[52]
L. P. Labranche, S. N. Dumont, S. Levesque, A. Carrier, "Rapid determination of total benzalkonium chloride content in ophthalmic formulation", J Pharm Biomed Anal., 43 (3); 989-93, 2006.
[53]
R. C. Meyer, "Determination of benzalkonium chloride by reversed-phase high-pressure liquid chromatography", J Pharm Sci., 69 (10): 1148-50, 1980.
[54]
P. Rojsitthisak, W. Wichitnithad, O. Pipitharome, K. Sanphanya, P. Thanawattanawanich, "Simple HPLC determination of benzalkonium chloride in ophthalmic formulations containing antazoline and tetrahydrozoline", PDA J Pharm Sci Technol., 59 (5); 332-7, 2005.
[55]
J. Zakrajšek, V. Stojic, S. Bohanec, U. Urleb, "Quality by design based optimization of a high performance liquid chromatography method for assay determination of low concentration preservatives in complex nasal formulations", Acta Chim Slov., 62 (1); 72-82, 2015.
[56]
E. Martínez-Carballo, C. González-Barreiro, A. Sitka, N. Kreuzinger, S. Scharf, O. Gans. “Determination of selected quaternary ammonium compounds by liquid chromatography with mass spectrometry. PartII. Application to sediment and sludge samples in Austria”|, Environ Pollut., 146 (2); 543-7, 2007.
[57]
H. AlAani, Y. AlNukkary. “Determination of Benzalkonium Chloride in Ophthalmic Solutions by Stability-Indicating HPLC Method: Application to a Stability Study”. Journal of Applied Pharmaceutical Science, 6 (05); 080-089, 2016.
[58]
M. E. M. Hassouna, M. M. Abdelrahman, M. A. Mohamed. “Simultaneous Determination of Azelastine hydrochloride and Benzalkonium chloride by RP-HPLC Method in their Ophthalmic Solution”. J Forensic Sci & Criminal Inves., 1 (3); 555565-75, 2017.
[59]
ICH, Q2(R1)Validation of Analytical Procedures: Text and Methodology. ICH Harmonized Tripartite Guideline, 2005.
ADDRESS
Science Publishing Group
1 Rockefeller Plaza,
10th and 11th Floors,
New York, NY 10020
U.S.A.
Tel: (001)347-983-5186